253 related articles for article (PubMed ID: 1760410)
1. Cell adhesion by membrane-bound paf-acether.
Ninio E; Leyravaud S; Bidault J; Jurgens P; Benveniste J
Int Immunol; 1991 Nov; 3(11):1157-63. PubMed ID: 1760410
[TBL] [Abstract][Full Text] [Related]
2. Triflavin potentiates the antiplatelet activity of platelet activating factor receptor antagonist on activated neutrophil-induced platelet aggregation.
Lee LW; Peng HC; Ko WC; Hung WC; Su CH; Lin CH; Huang TF; Yen MH; Sheu JR
Eur J Pharmacol; 1999 Jan; 364(2-3):239-46. PubMed ID: 9932729
[TBL] [Abstract][Full Text] [Related]
3. Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages.
Stewart AG; Dusting GJ
Br J Pharmacol; 1988 Aug; 94(4):1225-33. PubMed ID: 2850058
[TBL] [Abstract][Full Text] [Related]
4. Platelet-leukocyte interaction in adhesion to endothelial cells induced by platelet-activating factor in vitro.
Hirafuji M; Shinoda H
Br J Pharmacol; 1991 Jun; 103(2):1333-8. PubMed ID: 1884095
[TBL] [Abstract][Full Text] [Related]
5. Aggregation of human polymorphonuclear leukocytes by endothelin: role of platelet-activating factor.
Gómez-Garre D; Guerra M; González E; López-Farré A; Riesco A; Caramelo C; Escanero J; Egido J
Eur J Pharmacol; 1992 Dec; 224(2-3):167-72. PubMed ID: 1468506
[TBL] [Abstract][Full Text] [Related]
6. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds.
Baroggi N; Etienne A; Braquet P
Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of the platelet aggregation induced by activated neutrophils and inhibitory effect of specific PAF receptor antagonists.
Nguyên P; Petitfrère E; Potron G
Thromb Res; 1995 Apr; 78(1):33-42. PubMed ID: 7778064
[TBL] [Abstract][Full Text] [Related]
8. Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988.
Nunez D; Chignard M; Korth R; Le Couedic JP; Norel X; Spinnewyn B; Braquet P; Benveniste J
Eur J Pharmacol; 1986 Apr; 123(2):197-205. PubMed ID: 3086108
[TBL] [Abstract][Full Text] [Related]
9. PAF-acether (PAF) in Ehrlich ascites tumour cells.
Marathe GK; Krishnakanta TP; D'Souza CJ
J Lipid Mediat; 1990; 2(5):257-62. PubMed ID: 2133270
[TBL] [Abstract][Full Text] [Related]
10. Sensitization of human neutrophil defense activities through activation of platelet-activating factor receptors by ginkgolide B, a bioactive component of the Ginkgo biloba extract EGB 761.
Lenoir M; Pedruzzi E; Rais S; Drieu K; Perianin A
Biochem Pharmacol; 2002 Apr; 63(7):1241-9. PubMed ID: 11960600
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the metabolism of platelet activating factor (PAF-acether) by three specific antagonists from Ginkgo biloba.
Lamant V; Mauco G; Braquet P; Chap H; Douste-Blazy L
Biochem Pharmacol; 1987 Sep; 36(17):2749-52. PubMed ID: 2820421
[TBL] [Abstract][Full Text] [Related]
12. Comparison of three paf-acether receptor antagonist ginkgolides.
Korth R; Nunez D; Bidault J; Benveniste J
Eur J Pharmacol; 1988 Jul; 152(1-2):101-10. PubMed ID: 2850196
[TBL] [Abstract][Full Text] [Related]
13. [Effect of BN52021 on platelet activating factor induced aggregation of psoriatic polymorphonuclear neutrophils].
Liu BJ; Zhang HT; Zheng MR
Zhonghua Yi Xue Za Zhi; 1994 Jun; 74(6):370-2, 392. PubMed ID: 7994650
[TBL] [Abstract][Full Text] [Related]
14. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.
Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M
Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712
[TBL] [Abstract][Full Text] [Related]
15. Biosynthesis of paf-acether factor-acether by human skin fibroblasts in vitro.
Michel L; Denizot Y; Thomas Y; Jean-Louis F; Pitton C; Benveniste J; Dubertret L
J Immunol; 1988 Aug; 141(3):948-53. PubMed ID: 3397536
[TBL] [Abstract][Full Text] [Related]
16. Antagonists of PAF-acether do not suppress thrombin-induced aggregation of ADP-deprived and aspirin-treated human platelets.
Adnot S; Joseph D; Vargaftig BB
Agents Actions; 1987 Jun; 21(1-2):195-202. PubMed ID: 3115070
[TBL] [Abstract][Full Text] [Related]
17. Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking.
Lehr HA; Weyrich AS; Saetzler RK; Jurek A; Arfors KE; Zimmerman GA; Prescott SM; McIntyre TM
J Clin Invest; 1997 May; 99(10):2358-64. PubMed ID: 9153277
[TBL] [Abstract][Full Text] [Related]
18. Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation.
Golino P; Ambrosio G; Ragni M; Pascucci I; Triggiani M; Oriente A; McNatt J; Buja LM; Condorelli M; Chiariello M
Circulation; 1993 Sep; 88(3):1205-14. PubMed ID: 8353882
[TBL] [Abstract][Full Text] [Related]
19. Effects of platelet activating factor antagonists on arachidonic acid-induced platelet aggregation and TXA2 formation.
Heinroth-Hoffmann I; Hauser A; Mest HJ
Prostaglandins Leukot Essent Fatty Acids; 1990 Nov; 41(3):181-2. PubMed ID: 2149184
[TBL] [Abstract][Full Text] [Related]
20. Effect of BN 52021, a specific antagonist of platelet activating factor (PAF-acether), on calcium movements and phosphatidic acid production induced by PAF-acether in human platelets.
Simon MF; Chap H; Braquet P; Douste-Blazy L
Thromb Res; 1987 Feb; 45(4):299-309. PubMed ID: 3576518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]